News | PET-MRI | May 23, 2019

Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

French study uses MR Solutions’ cryogen-free 3T PET/MRI scanner to investigate promising improvements in imaging capabilities

Study Explores Magnetic Nanoparticles as Bimodal Imaging Agent for PET/MRI

Image courtesy of MR Solutions.

May 23, 2019 — Researchers from Bourgogne University in Dijon, France, showed that use of superparamagnetic iron oxide nanoparticles (NPs) using multimodal positron emission tomography/magnetic resonance imaging (PET/MRI) offers promising improvements in nuclear imaging capabilities. The paper is published in the American Chemical Society journal ACS Omega.1

Using an MR Solutions cryogen-free, 3 Tesla (3T) scanner with a PET clip on the sequential images were found to be highly beneficial providing high spatial resolution, high sensitivity and high technical maturity with a low radiation dose.

Prof. Nadine Millot, principal investigator on the study commented, “The combination of simultaneous MRI/PET imaging is very attractive because it allies the high resolution of MRI with the high sensitivity of PET to obtain accurate anatomical and quantitative information at the same time.” This pioneering imaging agent highlights activity in the liver, spleen, lungs and kidneys before being gradually excreted from the body, with no cytotoxicity observed.

This is the first successful grafting of PEG and MANOTA chelator on prefunctionalized iron oxide NPs synthesized under continuous hydrothermal conditions for bimodal PET/MRI imaging and shows the potential benefits.

For more information: www.pubs.acs.org

 

Reference

1. Thomas G., Boudon J., Maurizi L., et al. Innovative Magnetic Nanoparticles for PET/MRI Bimodal Imaging. ACS Omega, published online Feb. 5, 2019. https://doi.org/10.1021/acsomega.8b03283

Related Content

Nuclear Cardiology Optimistic About Return to Pre-COVID-19 Exam Levels. An American Society of Nuclear Cardiology (ASNC) member survey are confident nuclear cardiology volumes will return to pre-pandemic levels. #COVID19 #SARScov2
News | Nuclear Imaging | June 01, 2020
June 1, 2020 — While acknowledging the challenges their specialty is facing, more than two-thirds of respondents to a
The FDA has approved Lilly’s TAUVID (flortaucipir F 18 injection), a radioactive diagnostic agent, for PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease

Getty Images

News | Contrast Media | June 01, 2020
June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for...
MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

MERCK and RefleXion Medical announced a collaboration to evaluate KETRUDA (immunotherapy) with biology-guided radiotherapy - BgRT -  a new radiation machine developed to treat all stages of cancer.

 

News | Radiation Therapy | June 01, 2020
June 1, 2020 — RefleXion Medical, a therape
Colored areas of the brain represent regions where the loss of brain synapses in people with early-stage Alzheimer’s was greater than people with normal cognitive function.

Colored areas of the brain represent regions where the loss of brain synapses in people with early-stage Alzheimer’s was greater than people with normal cognitive function. Image courtesy of YaleNews.

News | PET Imaging | May 14, 2020
May 14, 2020 — New imaging technology allows scientists to see the widespread loss of brain synapses in early stages
The Society of Nuclear Medicine and Molecular Imaging's 2020 annual meeting has been reimagined, and is now the SNMMI 2020 Annual Meeting — Virtual Edition
News | Coronavirus (COVID-19) | April 30, 2020
April 30, 2020 — The Society of Nuclear Medicine and Molecular Imaging's 2020 annual meeting has been reimagined, and
#COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2 U.S. Army Spc. Jonathon Hyde and Spc. Casymn Harrison from the 1434th Engineer Company, Grayling, Mich., Michigan National Guard, prepare patient rooms at TCF Regional Care Center in Detroit in advance of receiving COVID-19 patients, April 9, 2020 #COVID19 #Coronavirus #2019nCoV #Wuhanvirus #SARScov2

U.S. Army Spc. Jonathon Hyde and Spc. Casymn Harrison from the 1434th Engineer Company, Grayling, Mich., Michigan National Guard, prepare patient rooms at TCF Regional Care Center in Detroit in advance of receiving COVID-19 patients, April 9, 2020. The TCF Center in Detroit has been converted into a 970-bed alternative care facility for COVID-19 patients by the Federal Emergency Management Agency, in partnership with the U.S. Army Corps of Engineers and Michigan National Guard. (Photo courtesy of U.S. Air National Guard photo by Master Sgt. Scott Thompson)

Feature | Coronavirus (COVID-19) | April 15, 2020 | By Melinda Taschetta-Millane and Dave Fornell
In an effort to keep the imaging field updated on the latest information being released on coronavirus (COVID-19), th
Maximum-intensity PET projections at each time point for one rhesus monkey in the 89Zr-DFO-squaramide-anti-gD group.

Maximum-intensity PET projections at each time point for one rhesus monkey in the 89Zr-DFO-squaramide-anti-gD group. Image courtesy of Eric Berg, University of California, Davis, CA

News | PET Imaging | April 10, 2020
April 10, 2020 — Combining 89Zr-labeled antibodies with total-body...